MedTrace Logo

Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure

NCT02766283 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 843

Last updated 2018-03-26

Study results available
· View outcomes & findings →

Summary

To investigate the incidence of detected hypothyroidism after iodinated contrast exposure in pediatric patients from birth to 3 years of age (inclusive) in a routine clinical practice setting.

Conditions

Interventions

DRUG

iodinated contrast agents

Intravascular application

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Max Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-08-30
Completion
2016-08-30
FDA Drug
Yes

Countries

  • Israel

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02766283 on ClinicalTrials.gov